Chronic Inflammation as a Potential Predictive Factor of Nivolumab Therapy in Non-small Cell Lung Cancer.
Svaton M, Zemanova M, Skrickova J, Jakubikova L, Kolek V, Kultan J, Koubkova L, Bejckova A, Salajka F, Hrnciarik M, Melichar B, Vrana D, Konecny M, Chloupkova R, Pesek M.
Svaton M, et al.
Anticancer Res. 2018 Dec;38(12):6771-6782. doi: 10.21873/anticanres.13048.
Anticancer Res. 2018.
PMID: 30504389